- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有98家主力机构披露2026-06-30报告期持股数据，持仓量总计9.53亿股，占流通A股48.63%
- 波段诊断：
-
技术面诊股
诊断结果：7.0技术面打败了83%的股票
技术面评分前10的股票
近期的平均成本为7.97元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为7.97元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"7.97","date":1793868225,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.11.06","stock":"-0.87","trade":"-2.28","ind":"-1.10"},{"date":"2026.11.05","stock":"0.25","trade":"2.50","ind":"0.10"},{"date":"2026.11.04","stock":"0.50","trade":"4.12","ind":"2.16"},{"date":"2026.11.03","stock":"1.01","trade":"-1.89","ind":"-0.82"},{"date":"2026.11.02","stock":"0.00","trade":"1.53","ind":"1.08"},{"date":"2026.10.30","stock":"1.41","trade":"-0.95","ind":"-1.44"},{"date":"2026.10.29","stock":"2.64","trade":"-2.31","ind":"-0.82"},{"date":"2026.10.28","stock":"-0.92","trade":"2.17","ind":"0.91"},{"date":"2026.10.27","stock":"-2.67","trade":"-4.09","ind":"-1.33"},{"date":"2026.10.26","stock":"1.03","trade":"0.93","ind":"0.19"},{"date":"2026.10.23","stock":"2.10","trade":"1.99","ind":"0.89"},{"date":"2026.10.22","stock":"-2.18","trade":"-3.56","ind":"-1.48"},{"date":"2026.10.21","stock":"0.13","trade":"0.04","ind":"-0.60"},{"date":"2026.10.20","stock":"-0.13","trade":"1.25","ind":"0.12"},{"date":"2026.10.19","stock":"0.78","trade":"-0.59","ind":"0.39"},{"date":"2026.10.16","stock":"0.13","trade":"-1.26","ind":"0.24"},{"date":"2026.10.15","stock":"-1.66","trade":"-1.68","ind":"-1.59"},{"date":"2026.10.14","stock":"0.00","trade":"-1.74","ind":"-0.88"},{"date":"2026.10.13","stock":"-0.13","trade":"-1.62","ind":"0.10"},{"date":"2026.10.12","stock":"-0.25","trade":"-3.02","ind":"-0.43"},{"date":"2026.10.09","stock":"1.42","trade":"1.49","ind":"0.05"}]
通化东宝,上证指数,生物制品指数
压力支撑
该股压力位为7.95元，支撑位为7.88元。
[{"text":"\u538b\u529b\u4f4d","value":"7.95","date":1793894400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.88","date":1793894400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.5资金面打败了6%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：11月06日 20:30
| 机构今日流向(万元) | -913.23 | 机构5日流向(万元) | 3574.23 |
| 机构10日流向(万元) | 1305.82 | 机构20日流向(万元) | -9233.44 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少6118.2万股，其中基金净减仓2家，主力净减仓231家，请投资者中长期谨慎为宜。
截止2026-06-30，共98家主力机构（基金93家，一般法人4家，QFII1家），持仓量总计95250.36万股，占流通A股48.63%
其中，基金持仓与2025-12-31相比：
增仓：33家 ，增持 1769.94万股
减仓：35家 ，减持 2429.02万股
新出现在主力名单中：20家 ，持有71.66万股
从主力名单中消失：251家 ，原持有3572.3万股
其中，基金持仓与2025-12-31相比：
增仓：33家 ，增持 1769.94万股
减仓：35家 ，减持 2429.02万股
新出现在主力名单中：20家 ，持有71.66万股
从主力名单中消失：251家 ，原持有3572.3万股
消息面诊股
诊断结果：5.5消息面打败了60%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 通化东宝：11月5日获融资买入1213.41万元
2026-11-06 - GLP-1热潮之下，下一代代谢疗法该去往何处？
2026-11-05 - 通化东宝：11月4日获融资买入1294.79万元
2026-11-05 - 河南通报：37家医药企业涉嫌在医药价格和招采环节失
2026-11-04 - 通化东宝：11月3日获融资买入971.07万元
2026-11-04 - 通化东宝：11月2日获融资买入1012.55万元
2026-11-03 - 通化东宝：10月30日获融资买入1281.69万元
2026-10-31 - GLP-1药物不断拓展新适应症，药企重金布局创新管
2026-10-30 - 通化东宝：10月29日获融资买入761.87万元
2026-10-30 - 通化东宝前三季度扣非净利润增长41% 人胰岛素市占
2026-10-29
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-09-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-08-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-08-12 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-07-29 |
| 一般消息 | 高管变动 | 因任期届满不再担任公司任何职务 | 2026-06-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-06-16 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-02 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-05-26 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-13 |
| 利好 | 分红转增 | 10派3元(含税) | 2026-04-20 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-01-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-31 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-01-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.7行业面打败了90%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2026.11.06","price":"-1.10","value":"-2.28"},{"date":"2026.11.05","price":"0.10","value":"2.50"},{"date":"2026.11.04","price":"2.16","value":"4.12"},{"date":"2026.11.03","price":"-0.82","value":"-1.89"},{"date":"2026.11.02","price":"1.08","value":"1.53"},{"date":"2026.10.30","price":"-1.44","value":"-0.95"},{"date":"2026.10.29","price":"-0.82","value":"-2.31"},{"date":"2026.10.28","price":"0.91","value":"2.17"},{"date":"2026.10.27","price":"-1.33","value":"-4.09"},{"date":"2026.10.26","price":"0.19","value":"0.93"},{"date":"2026.10.23","price":"0.89","value":"1.99"},{"date":"2026.10.22","price":"-1.48","value":"-3.56"},{"date":"2026.10.21","price":"-0.60","value":"0.04"},{"date":"2026.10.20","price":"0.12","value":"1.25"},{"date":"2026.10.19","price":"0.39","value":"-0.59"},{"date":"2026.10.16","price":"0.24","value":"-1.26"},{"date":"2026.10.15","price":"-1.59","value":"-1.68"},{"date":"2026.10.14","price":"-0.88","value":"-1.74"},{"date":"2026.10.13","price":"0.10","value":"-1.62"},{"date":"2026.10.12","price":"-0.43","value":"-3.02"},{"date":"2026.10.09","price":"0.05","value":"1.49"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | - | 21.52% | 1.77% | 分 |
| 2 | 我武生物 | 12.76% | 5.03% | 6.0分 |
| 3 | 康弘药业 | 11.37% | 22.39% | 6.1分 |
| 4 | 西藏药业 | 9.76% | 11.80% | 7.1分 |
| 5 | 智飞生物 | 8.83% | 10.53% | 6.4分 |
| 6 | 智翔金泰 | 6.57% | 14.96% | 6.4分 |
| 8 | 通化东宝 | 1.02% | 0.89% | 5.8分 |
| 10 | 派林生物 | -0.92% | 3.40% | 6.0分 |
| 12 | 上海莱士 | -2.37% | 4.44% | 5.9分 |
| 14 | 博雅生物 | -4.23% | 4.55% | 5.3分 |
| 16 | 甘李药业 | -5.48% | 4.51% | 5.6分 |
| 18 | 欧林生物 | -6.31% | 7.27% | 6.1分 |
| 20 | 康华生物 | -7.60% | 6.73% | 5.9分 |
| 22 | 百奥泰 | -7.93% | 8.62% | 5.0分 |
| 24 | 君实生物 | -8.81% | 6.53% | 5.4分 |
| 26 | 赛伦生物 | -10.47% | 2.70% | 4.8分 |
| 28 | 迈威生物 | -10.90% | 10.23% | 5.3分 |
| 30 | 东宝生物 | -11.55% | 3.81% | 5.8分 |
| 32 | 神州细胞 | -11.93% | 2.64% | 4.3分 |
| 34 | - | -13.24% | 3.21% | 分 |
| 36 | - | -13.58% | 0.57% | 分 |
| 38 | 博晖创新 | -14.91% | 1.35% | 4.7分 |
| 40 | 诺唯赞 | -16.47% | -1.59% | 6.1分 |
| 42 | 万泽股份 | -17.56% | 7.33% | 5.4分 |
| 44 | 优宁维 | -20.18% | -0.10% | 5.0分 |
| 46 | 近岸蛋白 | -21.45% | -16.05% | 5.6分 |
| 48 | 沃森生物 | -22.37% | 5.14% | 4.5分 |
| 50 | 泰诺麦博 | -24.52% | 6.71% | 5.4分 |
| 52 | 艾迪药业 | -25.27% | -1.34% | 4.4分 |
| 54 | 百普赛斯 | -28.71% | -15.83% | 5.7分 |
| 56 | 科兴制药 | -33.18% | -1.96% | 4.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 10/74 ， 27/74。
[{"date":"2026-09-30","value":"7.40","vol":"-8.23"},{"date":"2026-06-30","value":"4.24","vol":"-7.86"},{"date":"2026-03-31","value":"1.77","vol":"-6.34"},{"date":"2025-12-31","value":"18.08","vol":"-12.02"},{"date":"2025-09-30","value":"17.80","vol":"-9.71"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.40 | 4.24 | 1.77 | 18.08 | 17.80 |
| 行业(%) | -8.23 | -7.86 | -6.34 | -12.02 | -9.71 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"70.84","vol":"53.64"},{"date":"2026-06-30","value":"70.79","vol":"56.17"},{"date":"2026-03-31","value":"71.62","vol":"60.27"},{"date":"2025-12-31","value":"70.33","vol":"65.27"},{"date":"2025-09-30","value":"71.89","vol":"67.57"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
70.84 | 70.79 | 71.62 | 70.33 | 71.89 |
| 行业(%) | 53.64 | 56.17 | 60.27 | 65.27 | 67.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，两项指标的行业排名分别为 20/74 ， 41/74。
[{"date":"2026-09-30","value":"11.66","vol":"17.56"},{"date":"2026-06-30","value":"11.13","vol":"30.57"},{"date":"2026-03-31","value":"14.76","vol":"291.45"},{"date":"2025-12-31","value":"46.66","vol":"39.10"},{"date":"2025-09-30","value":"50.55","vol":"44.08"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
11.66 | 11.13 | 14.76 | 46.66 | 50.55 |
| 行业(%) | 17.56 | 30.57 | 291.45 | 39.10 | 44.08 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"-56.20","vol":"44.90"},{"date":"2026-06-30","value":"37.32","vol":"18.61"},{"date":"2026-03-31","value":"16.16","vol":"71.92"},{"date":"2025-12-31","value":"3005.63","vol":"36.03"},{"date":"2025-09-30","value":"1911.35","vol":"43.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-56.20 | 37.32 | 16.16 | 3005.63 | 1911.35 |
| 行业(%) | 44.90 | 18.61 | 71.92 | 36.03 | 43.94 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 8/74 ， 12/74。
[{"date":"2026-09-30","value":"0.31","vol":"0.21"},{"date":"2026-06-30","value":"0.20","vol":"0.14"},{"date":"2026-03-31","value":"0.09","vol":"0.06"},{"date":"2025-12-31","value":"0.39","vol":"0.30"},{"date":"2025-09-30","value":"0.28","vol":"0.21"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.31 | 0.20 | 0.09 | 0.39 | 0.28 |
| 行业(次) | 0.21 | 0.14 | 0.06 | 0.30 | 0.21 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.08","vol":"0.98"},{"date":"2026-06-30","value":"0.66","vol":"0.62"},{"date":"2026-03-31","value":"0.32","vol":"0.28"},{"date":"2025-12-31","value":"1.21","vol":"1.26"},{"date":"2025-09-30","value":"0.83","vol":"0.86"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.08 | 0.66 | 0.32 | 1.21 | 0.83 |
| 行业(次) | 0.98 | 0.62 | 0.28 | 1.26 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"28.93","vol":"-2949.98"},{"date":"2026-06-30","value":"33.55","vol":"-1266.35"},{"date":"2026-03-31","value":"35.15","vol":"-144.81"},{"date":"2025-12-31","value":"40.25","vol":"-237.25"},{"date":"2025-09-30","value":"7.80","vol":"-11.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 28.93 | 33.55 | 35.15 | 40.25 | 7.80 |
| 行业 | -2949.98 | -1266.35 | -144.81 | -237.25 | -11.00 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"1.21","vol":"1.58"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.72","vol":"1.73"},{"date":"2025-09-30","value":"","vol":"0.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.21 | - | 1.72 | - |
| 行业 | 0.00 | 1.58 | 0.00 | 1.73 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 28/74 ， 30/74。
[{"date":"2026-09-30","value":"4.19","vol":"5.72"},{"date":"2026-06-30","value":"3.63","vol":"5.75"},{"date":"2026-03-31","value":"4.84","vol":"6.58"},{"date":"2025-12-31","value":"5.04","vol":"5.74"},{"date":"2025-09-30","value":"4.64","vol":"5.84"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.19 | 3.63 | 4.84 | 5.04 | 4.64 |
| 行业 | 5.72 | 5.75 | 6.58 | 5.74 | 5.84 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"3.16","vol":"4.34"},{"date":"2026-06-30","value":"2.59","vol":"4.33"},{"date":"2026-03-31","value":"3.61","vol":"5.09"},{"date":"2025-12-31","value":"3.65","vol":"4.39"},{"date":"2025-09-30","value":"3.38","vol":"4.70"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.16 | 2.59 | 3.61 | 3.65 | 3.38 |
| 行业 | 4.34 | 4.33 | 5.09 | 4.39 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 38/74 ， 41/74。
[{"date":"2026-09-30","value":"12.51","vol":"29.36"},{"date":"2026-06-30","value":"12.95","vol":"29.58"},{"date":"2026-03-31","value":"12.27","vol":"29.49"},{"date":"2025-12-31","value":"10.10","vol":"29.33"},{"date":"2025-09-30","value":"12.46","vol":"26.96"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
12.51 | 12.95 | 12.27 | 10.10 | 12.46 |
| 行业(%) | 29.36 | 29.58 | 29.49 | 29.33 | 26.96 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.14","vol":"1.84"},{"date":"2026-06-30","value":"0.15","vol":"1.35"},{"date":"2026-03-31","value":"0.14","vol":"2.52"},{"date":"2025-12-31","value":"0.11","vol":"1.42"},{"date":"2025-09-30","value":"0.14","vol":"0.56"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.14 | 0.15 | 0.14 | 0.11 | 0.14 |
| 行业(%) | 1.84 | 1.35 | 2.52 | 1.42 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 兴业证券 | 2026-09-10 | 增持 | |
| 华泰证券 | 2026-09-03 | 买入 | 买入 |
| 东方证券 | 2026-09-02 | 买入 | |
| 中信建投证券 | 2026-09-02 | 买入 | |
| 华兴证券 | 2026-08-28 | 增持 | |
| 平安证券 | 2026-08-26 | 增持 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"15.82","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.42","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"12.19","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"6.19","blueLineValue":"0.32","type":"YC"}]